Quantcast

Latest Acetonide Stories

2014-10-14 16:28:47

WASHINGTON, Oct. 14, 2014 /PRNewswire/ -- Thirty-one former customers have filed suit in New Jersey State Court against Mario Badescu, Inc., a skincare company based out of Edison, New Jersey, and Mario Badescu Skin Care, Inc., a skincare salon in New York. The plaintiffs allege that they were injured by potent and undisclosed steroids in two of Mario Badescu's face creams, Control Cream and Healing Cream, which were marketed as products that contained only "botanical" active...

2014-09-26 16:23:57

Company will issue a more detailed announcement on Monday, September 29 ATLANTA, Sept. 26, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved ILUVIEN(®) for the treatment of diabetic macular edema (DME) in patients who have been previously treated...

2014-04-28 08:30:58

-- Intravitreal corticosteroid implant for treatment of vision impairment associated with diabetic macular oedema MELBOURNE, Australia and ATLANTA, April 28, 2014 /PRNewswire/ -- Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia (STA) and Alimera Sciences (NASDAQ: ALIM). The exclusive...

2014-04-14 12:33:11

PDUFA goal date set for September 26, 2014 ATLANTA, April 14, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that its recent resubmission of the New Drug Application (NDA) for ILUVIEN(®) has been acknowledged as received by the U.S. Food and Drug Administration (FDA) as a complete class 2 response to the...

2013-07-31 23:18:37

David P. Skoner, MD, of Allegheny General Hospital was chosen to represent the opinions of major national allergy medicine societies in opposing the over-the-counter sale of triamcinolone acetonide (Nasacort) to kids and adults. Silver Spring, Md. (PRWEB) July 31, 2013 David P. Skoner, MD, Director of the Division of Allergy, Asthma and Immunology, Department of Medicine at Allegheny General Hospital (AGH), will testify today before the U.S. Food and Drug Administration in opposition to...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.